Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma

Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
Pınar CömertMeltem Aylı

Abstract

Low-grade Nonhodgkin lymphoma (LG-NHL) is characterized by indolent clinical course, which consist of marginal zone lymphoma (MZL), follicular lymphoma (FL), chronic lymphocytic leukemia/small lymphocytic lymphoma, lymphoplasmacytic lymphoma, waldenstrom macroglobulinemia (WM) as the most common subtypes. Factors affecting prognosis and treatment need in these patients have long been the subject of research. A retrospective study was conducted with patients diagnosed with LG-NHL in Hematology Departments of two centres between 2010 and 2018. At the time of diagnosis, demographic and disease characteristics, hematological and biochemical parameters were examined. Using these data, treatment requirements, response and survival rates were calculated. The effect of parameters on survival and need to treatment were analyzed. 93 LG-NHL patients were included in this study. 40 (43%) of these patients were MZL, 28 (30.1%) were FL and 25 (26.8%) were others. In comparison of patients required treatment with patients without treatment, there was significant difference among the number of comorbidity, platelet count, neutrophil count, disease subgroups and ferritin levels. Logistic regression analysis revealed that disease subgroup (other...Continue Reading

References

Apr 1, 1990·Onkologie·E Aulbert, O Steffens
Dec 15, 1983·Cancer·M H DörnerP Drings
Jan 1, 1980·American Journal of Hematology·Y MatznerC Hershko
Nov 25, 2006·Hematology·Laurie H Sehn
Jan 15, 2008·Journal of Autoimmunity·Stefania RecalcatiGaetano Cairo
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoPhilippe Solal-Céligny
Mar 30, 2010·Biochimica Et Biophysica Acta·Ahmed A Alkhateeb, James R Connor
Apr 29, 2010·Current Hematologic Malignancy Reports·Massimo FedericoStefano Luminari
Aug 10, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Marta KalousováTomáš Zima
Aug 25, 2012·TheScientificWorldJournal·Luca ArcainiStefano Luminari
Aug 16, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Xue-Zhong ZhangYan-Li Xu
Nov 26, 2016·International Journal of Laboratory Hematology·S KoyamaH Nakajima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
S Ben-HaimD Front
Current Treatment Options in Oncology
Catherine Thieblemont, B Coiffier
© 2021 Meta ULC. All rights reserved